Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

What is an Advance Market Commitment?

CGDThe essence of an advance market commitment is that sponsors would guarantee that, if a suitable vaccine is developed, they will pay for it to be bought and used in developing countries.

Clinical Trials for New TB Vaccine Begin

AERASThe Aeras Global TB Vaccine Foundation and the David Geffen School of Medicine at UCLA today announced they have begun the first clinical trial of a live recombinant tuberculosis vaccine in the U.S.

About Vaccines for Development

CGDImmunization is one of the safest ways to reduce disease and poverty in developing countries. But 3 million people die every year of vaccine-preventable diseases; and that will likely rise to 4.5 million when rotavirus and pneumococcus vaccines are available, if past experience is any guide. And progress towards vaccines suitable for HIV, malaria and tuberculosis is painfully slow.

Solving the Real Vaccine Shortage

As the most fragile Americans line up for a dwindling supply of flu shots, many people are wondering why vaccines, arguably the most essential and cost-effective pharmaceutical products, seem to be one of the health system’s weakest links. Americans are discovering what people in the developing world have long known: on their own, markets fail to provide the right vaccines when and where they are needed most.

Pages